Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2010 7
2011 8
2012 11
2013 14
2014 8
2015 14
2016 12
2017 9
2018 15
2019 9
2020 3
2021 7
2022 6
2023 6
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
Kampylafka E, Simon D, d'Oliveira I, Linz C, Lerchen V, Englbrecht M, Rech J, Kleyer A, Sticherling M, Schett G, Hueber AJ. Kampylafka E, et al. Among authors: englbrecht m. Arthritis Res Ther. 2019 Jul 26;21(1):178. doi: 10.1186/s13075-019-1957-0. Arthritis Res Ther. 2019. PMID: 31349876 Free PMC article. Clinical Trial.
[Flexor-tendon-injury of the hand].
Englbrecht MA, Frank K, Giunta RE. Englbrecht MA, et al. MMW Fortschr Med. 2019 Jun;161(12):47-48. doi: 10.1007/s15006-019-0659-5. MMW Fortschr Med. 2019. PMID: 31230307 German. No abstract available.
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.
Strunz PP, Englbrecht M, Risser LM, Witte T, Froehlich M, Schmalzing M, Gernert M, Schmieder A, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Heck J, Welcker M, Kleinert S. Strunz PP, et al. Among authors: englbrecht m. Rheumatol Int. 2024 Oct;44(10):2057-2066. doi: 10.1007/s00296-024-05671-9. Epub 2024 Aug 13. Rheumatol Int. 2024. PMID: 39136784 Free PMC article.
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial.
Knitza J, Tascilar K, Fuchs F, Mohn J, Kuhn S, Bohr D, Muehlensiepen F, Bergmann C, Labinsky H, Morf H, Araujo E, Englbrecht M, Vorbrüggen W, von der Decken CB, Kleinert S, Ramming A, Distler JHW, Bartz-Bazzanella P, Vuillerme N, Schett G, Welcker M, Hueber A. Knitza J, et al. Among authors: englbrecht m. J Med Internet Res. 2024 Jul 23;26:e55542. doi: 10.2196/55542. J Med Internet Res. 2024. PMID: 39042425 Free PMC article. Clinical Trial.
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database.
Strunz PP, Englbrecht M, Risser LM, Witte T, Froehlich M, Schmalzing M, Gernert M, Schmieder A, Bartz-Bazzanella P, von der Decken C, Karberg K, Gauler G, Wurth P, Späthling-Mestekemper S, Kuhn C, Vorbrüggen W, Heck J, Welcker M, Kleinert S. Strunz PP, et al. Among authors: englbrecht m. Front Immunol. 2024 May 23;15:1395968. doi: 10.3389/fimmu.2024.1395968. eCollection 2024. Front Immunol. 2024. PMID: 38846940 Free PMC article.
109 results